Operose Advisors’s Vaxart VXRT Stock Holding History

Operose Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,500	Closed	-$8K	–	384
2022 Q3	$8K	Buy	+3,500	New	+$12.1K	0.01%	288

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Operose Advisors's VXRT Position: Q4 2022 in Review

Operose Advisors sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 3,500 shares — an estimated $8K sold.

Operose Advisors first reported a position in VXRT in Q3 2022 and held it in 1 quarter. The position peaked at $8K in Q3 2022. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

Operose Advisors reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
Operose Advisors sold 3,500 Vaxart shares in Q4 2022, an estimated $8K.
Operose Advisors first reported a position in Vaxart in Q3 2022 and held it in 1 quarter.
Operose Advisors's Vaxart position peaked at $8K in Q3 2022.
132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Operose Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.